A Long-term Follow-up Study in Subjects Who Received CTX001
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Beta Thalassemia
- Genetic Diseases, Inborn
- "Hematologic Diseases"
- Hemoglobinopathies
- Sickle Cell Anemia
- Sickle Cell Disease
- ? Thalassemia
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04208529
- Collaborators
- CRISPR Therapeutics
- Investigators
- Not Provided
Get Well Soon